Literature DB >> 18344437

Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography.

Maria Picchio1, Roswitha Beck, Roland Haubner, Stefan Seidl, Hans-Jürgen Machulla, Timothy D Johnson, Hans-Jürgen Wester, Gerald Reischl, Markus Schwaiger, Morand Piert.   

Abstract

UNLABELLED: The hypoxia-inducible factor-1 alpha (HIF-1 alpha) activates angiogenesis in response to cellular hypoxia, suggesting a spatial correlation between angiogenesis and tissue hypoxia.
METHODS: Using digital autoradiography of coinjected 18F-labeled azomycin arabinoside (8F-FAZA) (assessing regional hypoxia) and a glycosylated RGD-containing peptide (125I-3-iodo-dTyr(4)-cyclo(-Arg-Gly-Asp-dTyr-Lys(SAA)-), or 125I-Gluco-RGD) (assessing angiogenesis via binding to alpha v beta 3 integrin receptors on endothelial cells) performed on 22 EMT6 tumor xenografts, we investigated the intratumoral spatial distribution of these tracers. We applied a Bayesian bivariate image analysis using the mean tumor-to-muscle ratio as a discriminator, resulting in 4 groups: FAZA high/RGD high (Q1), FAZA low/RGD high (Q2), FAZA low/RGD low (Q3), and FAZA high/RGD low (Q4). In an additional 18 xenografts, the immunohistochemically derived HIF-1 alpha protein distribution was compared with 18F-FAZA autoradiography. Animals were divided into groups breathing either room air or carbogen (95% oxygen, 5% CO2) for 4 h until sacrifice.
RESULTS: Under room air conditions, roughly 60% of the tumor surface displayed a spatial coupling of 18F-FAZA and 125I-Gluco-RGD uptake: either high (Q1) or low (Q3) uptake for both tracers, with Q1 indicating spatial association of hypoxia and angiogenesis and Q3 indicating adequate oxygenation without active angiogenesis. However, the remaining approximately 40% of the tumor surface showed discordant 18F-FAZA and 125I-Gluco-RGD uptake, indicating that hypoxia and angiogenesis are not necessarily spatially linked to each other and highlighting substantial intratumoral heterogeneity of the 18F-FAZA and 125I-Gluco-RGD uptake. Although carbogen breathing conditions significantly decreased the mean 18F-FAZA tumor-to-muscle ratio, no significant changes were observed for 125I-Gluco-RGD, indicating that an acute increase in tumor oxygenation did not influence alpha v beta 3 integrin receptor expression. The HIF-1 alpha-positive (HIFpos) tumor cell fraction was not significantly influenced by breathing conditions and covered between 0% and 35% of the total tumor section surface. However, the HIFpos tumor section surface was much smaller than the tumor section surface of increased 18F-FAZA uptake, suggesting that both markers are identifying distinctly different biologic processes associated with hypoxia.
CONCLUSION: The study revealed a substantial spatial discordance of the 18F-FAZA and 125I-Gluco-RGD tumor distribution suggesting that hypoxia and angiogenesis are not necessarily spatially linked in malignancies. These results may prove essential in developing advanced targeted systemic chemotherapeutic approaches (such as combinations of hypoxia-activated cytotoxins and antiangiogenic drugs) for hypoxic tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18344437     DOI: 10.2967/jnumed.107.046870

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  13 in total

Review 1.  Tumor cell plasticity: the challenge to catch a moving target.

Authors:  Sarah Schwitalla
Journal:  J Gastroenterol       Date:  2014-02-25       Impact factor: 7.527

2.  18F-FAZA PET imaging response tracks the reoxygenation of tumors in mice upon treatment with the mitochondrial complex I inhibitor BAY 87-2243.

Authors:  Edwin Chang; Hongguang Liu; Kerstin Unterschemmann; Peter Ellinghaus; Shuanglong Liu; Volker Gekeler; Zhen Cheng; Dietmar Berndorff; Sanjiv S Gambhir
Journal:  Clin Cancer Res       Date:  2014-11-07       Impact factor: 12.531

3.  Tumor hypoxia imaging.

Authors:  Xilin Sun; Gang Niu; Nicholas Chan; Baozhong Shen; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2011-06       Impact factor: 3.488

4.  PET imaging of hypoxia-inducible factor-1-active tumor cells with pretargeted oxygen-dependent degradable streptavidin and a novel 18F-labeled biotin derivative.

Authors:  Takashi Kudo; Masashi Ueda; Hiroaki Konishi; Hidekazu Kawashima; Yuji Kuge; Takahiro Mukai; Azusa Miyano; Shotaro Tanaka; Shinae Kizaka-Kondoh; Masahiro Hiraoka; Hideo Saji
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

5.  Breast cancer redox heterogeneity detectable with chemical exchange saturation transfer (CEST) MRI.

Authors:  Kejia Cai; He N Xu; Anup Singh; Lily Moon; Mohammad Haris; Ravinder Reddy; Lin Z Li
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

Review 6.  Positron emission tomography to assess hypoxia and perfusion in lung cancer.

Authors:  Eline E Verwer; Ronald Boellaard; Astrid Am van der Veldt
Journal:  World J Clin Oncol       Date:  2014-12-10

7.  Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies.

Authors:  Sander Bins; Geert A Cirkel; Christa G Gadellaa-Van Hooijdonk; Fleur Weeber; Isaac J Numan; Annette H Bruggink; Paul J van Diest; Stefan M Willems; Wouter B Veldhuis; Michel M van den Heuvel; Rob J de Knegt; Marco J Koudijs; Erik van Werkhoven; Ron H J Mathijssen; Edwin Cuppen; Stefan Sleijfer; Jan H M Schellens; Emile E Voest; Marlies H G Langenberg; Maja J A de Jonge; Neeltje Steeghs; Martijn P Lolkema
Journal:  Oncologist       Date:  2016-09-23

8.  18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression.

Authors:  Shuanglong Liu; Zhaofei Liu; Kai Chen; Yongjun Yan; Petra Watzlowik; Hans-Jürgen Wester; Frederick T Chin; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2009-12-01       Impact factor: 3.488

9.  DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6.

Authors:  J P B O'Connor; C J Rose; A Jackson; Y Watson; S Cheung; F Maders; B J Whitcher; C Roberts; G A Buonaccorsi; G Thompson; A R Clamp; G C Jayson; G J M Parker
Journal:  Br J Cancer       Date:  2011-06-14       Impact factor: 7.640

10.  Quantum dots for cancer research: current status, remaining issues, and future perspectives.

Authors:  Min Fang; Chun-Wei Peng; Dai-Wen Pang; Yan Li
Journal:  Cancer Biol Med       Date:  2012-09       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.